The Netherlands Respiratory Devices Market is expected to grow with a CAGR of 9.6% in the forecast period. The rise in the number of respiratory disorders, chronic obstructive pulmonary disease patients (COPD), TB, asthma, and pneumonia cases remains the major driver of the market.
Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and tuberculosis.
Asthma is one of the largest contributors to this figure, affecting children, adults, and elderly people in the Netherlands. According to the Lung Foundation Netherlands, there are over a million people suffering from lung disease, like asthma, COPD, and other lung diseases. Therefore the high burden of asthma, COPD, and other lung diseases helps in boosting the demand for respiratory devices in the market. Furthermore, with the recent COVID-19 outbreak, the demand for respiratory devices like ventilators has increased rapidly.
Key Market Trends
Therapeutic Devices are Expected to Grow Fastest During the Forecasted Period
Recently, due to the COVID pandemic, the therapeutic devices have been in high demand in the market. Therapeutic devices like ventilators are found to provide mechanical ventilation by moving breathable air into and out of the lungs, to deliver breath to a patient who is physically unable to breathe, or breathing insufficiently.
According to the Lancet Journal 2019, an estimated 100,000 children suffer from asthma in the Netherlands for the year and the number is expected to increase propelling the use of therapeutic respiratory devices. Furthermore, the novel COVID 19 pandemic has increased the demand for ventilator devices drastically. Therefore the high number of COVID cases increasing on a daily basis has posed a huge demand for the therapeutic devices in the market.
The Netherlands Respiratory Devices Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players are DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare, Getinge AB, GlaxoSmithKline PLC.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support